REFRACTORY SOLID TUMOR
Clinical trials for REFRACTORY SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY SOLID TUMOR trials appear
Sign up with your email to follow new studies for REFRACTORY SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug TURALIO takes on tough childhood cancers in early trial
Disease control Recruiting nowThis early-phase study tests the drug TURALIO (pexidartinib) in people aged 3 to 35 whose cancer has not responded to standard treatments. The goal is to find a safe dose and see if it can shrink tumors or control leukemia. Participants take a daily capsule for up to 2 years, wit…
Matched conditions: REFRACTORY SOLID TUMOR
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New cocktail of four drugs aims to tackle childhood cancers that Won't go away
Disease control Recruiting nowThis study is testing a combination of four drugs—atezolizumab, sorafenib, bevacizumab, and cyclophosphamide—in children and young adults with solid tumors that have come back or not responded to standard treatment. The goal is to find safe doses and see if the combination can sh…
Matched conditions: REFRACTORY SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New pill takes on tough cancers in first human test
Disease control Recruiting nowThis early-stage trial tests an experimental oral drug called CID-078 in 220 adults with advanced solid tumors that have not responded to standard treatments. The study is split into two parts: first, finding a safe dose, and then checking if the drug shrinks tumors. It is a firs…
Matched conditions: REFRACTORY SOLID TUMOR
Phase: PHASE1 • Sponsor: Circle Pharma • Aim: Disease control
Last updated Jun 26, 2026 17:08 UTC